Kursprognose für Scribe Therapeutics Inc. Common Stock (SCTX)SCTXScribe Therapeutics Inc. Common Stock

Alphio's SCTX stock price prediction model matches the current Scribe Therapeutics Inc. Common Stock tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.84 (+0.34%). The 1-week path is $16.95 (+1.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Scribe Therapeutics is currently trading at $15.54, which is significantly below the analyst price target of $60, indicating potential for substantial upside. However, the RSI is at 32.944, suggesting the stock is oversold, which could lead to a short-term rebound. The company has reported a gross margin of 100%, but it is facing significant net losses, with a net income of -6.48 million in Q2 2026. The main risk is the company's negative earnings per share of -0.37 and ongoing concerns about long-term profitability and market acceptance of its gene-editing platform.

Scribe Therapeutics Inc. Common Stock (SCTX) last closed at $16.7800007, gaining +3.58%. These facts feed the 1-day and 1-week SCTX price prediction above.